Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia.
about
Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid Derived Suppressor Cells.HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma.Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin.Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report.Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
P2860
Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthetic high-density lipopro ...... chronic lymphocytic leukemia.
@en
Synthetic high-density lipopro ...... chronic lymphocytic leukemia.
@nl
type
label
Synthetic high-density lipopro ...... chronic lymphocytic leukemia.
@en
Synthetic high-density lipopro ...... chronic lymphocytic leukemia.
@nl
prefLabel
Synthetic high-density lipopro ...... chronic lymphocytic leukemia.
@en
Synthetic high-density lipopro ...... chronic lymphocytic leukemia.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Synthetic high-density lipopro ...... chronic lymphocytic leukemia.
@en
P2093
C Shad Thaxton
Elad Deiss-Yehiely
Federica Barbaglio
Francis J Giles
Jason Kaplan
Kaylin M McMahon
Leo I Gordon
Lydia Scarfo
Pamela Ranghetti
P2860
P304
11219-11227
P356
10.18632/ONCOTARGET.14494
P407
P577
2017-01-04T00:00:00Z